Original articleMycoplasma pneumoniae–induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme: A systematic review
Section snippets
Search strategies
A comprehensive search of the English-language literature was performed on 3 databases: Ovid MEDLINE, PubMed, and EMBASE. Search terms included: “Mycoplasma pneumoniae” or “atypical pneumonia” and “Stevens-Johnson syndrome,” “erythema multiforme,” “toxic epidermal necrolysis,” “mucositis,” “atypical Stevens-Johnson syndrome,” “Fuchs syndrome,” or “Mycoplasma pneumoniae–associated mucositis.” Bibliographies of select publications were reviewed for eligible studies.
Data sources
We included abstracts, case
Results
In all, 256 potential cases of Mycoplasma-associated mucocutaneous disease were identified from 107 reports, of which 202 patients from 95 articles satisfied the inclusion criteria. Twelve articles (54 patients) were excluded because of insufficient morphologic or clinical documentation.2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
Discussion
This systematic review highlights the morphology and clinical course of M pneumoniae–associated mucocutaneous disease that support its designation as a distinct clinical entity. Key features that help to distinguish MIRM from herpes-related erythema multiforme or drug-induced SJS/TEN include young patients, predominance of mucosal involvement, variable though relatively sparse cutaneous involvement, and excellent prognosis.
Despite these differences, most cases of M pneumoniae–associated
References (0)
Cited by (233)
Conservative management of Mycoplasma pneumoniae-induced Stevens Johnson syndrome in a paediatric patient: A case report
2024, Pediatric Dental JournalPreliminary summary and reclassification of cases from the Pediatric Research of Management in Stevens-Johnson syndrome and Epidermonecrolysis (PROMISE) study: A North American, multisite retrospective cohort
2024, Journal of the American Academy of DermatologyReactive Infectious Mucocutaneous Eruption (RIME): Expanding the Spectrum of Mucocutaneous Exanthems
2024, Actas Dermo-SifiliograficasRecurrent reactive infectious mucocutaneous eruption: A retrospective cohort study
2023, Journal of the American Academy of DermatologyOcular involvement in Mycoplasma induced rash and mucositis: A systematic review of the literature
2023, Ocular SurfaceCitation Excerpt :MIRM is a relatively newly identified phenomenon in the medical literature and its characterization is evolving. Canavan et al. first described the entity and provided thorough insights on its epidemiology and manifestations in 2015 [16]. In this review, we sought to review existing cases reporting a diagnosis of MIRM after the establishment of the clinical entity by Canavan et al. and with ocular data.
The reference list for this article is available at http://www.jaad.org.
Funding sources: None.
Conflicts of interest: None declared.